SUPRAFLEX CRUZ PMCF Study ( rEpic05 )

Recruiting now

Conditions studied: Coronary Artery Disease (CAD), Ischemic Heart Disease

In brief

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Medical Device Regulations (MDR) with multivessel coronary disease requirements in all the CONSECUTIVE patients treated with (SUPRAFLEX CRUZ).

Key facts

Study ID
NCT05617599
Run by
Fundación EPIC
People needed
508
Starts
2023-05-10
Expected to finish
2026-12-01
Last updated by the study team
2025-12-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.